Evidence map›Paper›PMID 38841147›Full record

ArticleJournal of the Canadian Association of Gastroenterology2024

Success of

Thomas Krahn, Jonas Buttenschoen, Pernilla D'Souza, Safwat Girgis, Aducio Thiesen, Robert Rennie, LeeAnn Turnbull, Sander Veldhuyzen van Zanten

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Canadian Association of Gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Do the new ACGJournal of the Canadian Association of Gastroenterology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thomas KrahnDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0002-6245-4134
Jonas ButtenschoenUniversity of Erlangen-Nuremberg, Erlangen, Germany.
Pernilla D'SouzaDivision of Gastroenterology, Department of Medicine, Trillium Health Partners, Mississauga, Canada.
Safwat GirgisDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Aducio ThiesenDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Robert RennieDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
LeeAnn TurnbullAlberta Precision Laboratories, Edmonton, Canada.
Sander Veldhuyzen van ZantenDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Updated 2016 Objectives: This was a retrospective cohort study to describe and compare the efficacy of anti- Methods: A modified intention-to-treat (mITT) analysis was used to analyze the success rate of therapies. mITT includes all patients who were prescribed Results: Conclusions: Algorithmic treatment with PAMC first line followed by PBMT, PAL, and PAR cures

Indexed as

antibiotic resistanceHelicobacter pylori

Identifiers

PMID38841147
PMCPMC11149661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.